Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138804577> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2138804577 endingPage "898" @default.
- W2138804577 startingPage "885" @default.
- W2138804577 abstract "Repaglinide (NovoNorm((R))) is a novel oral antidiabetic agent, the first of a new class of insulin secretagogues known as the prandial glucose regulators to be approved for use in patients with Type 2 diabetes. Prandial glucose regulation is aimed at restoring the first-phase insulin response that follows consumption of a meal, which is missing in patients with Type 2 diabetes. After repaglinide administration, the resulting insulin profile reflects that of healthy individuals more closely, providing tighter glycaemic control and reducing the risk of hypoglycaemic events. Repaglinide is quickly absorbed and rapidly eliminated through biliary excretion, making it suitable for use in patients with renal impairment. It appears in the bloodstream within 15 to 30 min of dosing, stimulating short-term insulin release from the pancreatic beta-cells by binding to a unique site on the beta-cell membrane. Rapid elimination ensures that postprandial insulin levels quickly return to preprandial levels as the high prandial glucose level subsides. Repaglinide is given on a 'one meal, one tablet; no meal, no tablet' basis. It is particularly effective in patients who have not previously been treated with an oral antidiabetic agent, significantly reducing glycosylated haemoglobin (HbA(1c)) levels by 1.6%. It also offers increased mealtime flexibility and safety, compared with other oral antidiabetic agents. As a result of the short plasma half-life and lack of accumulation of repaglinide with repeated dosing, the risk of between-meal and nocturnal hypoglycaemia is substantially reduced compared with other oral antidiabetic agents. Repaglinide acts synergistically with metformin, consistently improving glycaemic control in patients who were insufficiently controlled by metformin alone. Results from recent studies have shown similar synergistic effects with neutral protamine Hagedorn (NPH)-insulin or troglitazone." @default.
- W2138804577 created "2016-06-24" @default.
- W2138804577 creator A5026124381 @default.
- W2138804577 creator A5041407449 @default.
- W2138804577 date "2000-04-01" @default.
- W2138804577 modified "2023-09-27" @default.
- W2138804577 title "Pharmacology and clinical experience with repaglinide" @default.
- W2138804577 cites W1966878411 @default.
- W2138804577 cites W1980289889 @default.
- W2138804577 cites W1989089571 @default.
- W2138804577 cites W2024909232 @default.
- W2138804577 cites W2053670472 @default.
- W2138804577 cites W2068097983 @default.
- W2138804577 cites W2081805412 @default.
- W2138804577 cites W2082799310 @default.
- W2138804577 cites W2096967744 @default.
- W2138804577 cites W2123147731 @default.
- W2138804577 cites W2127119840 @default.
- W2138804577 cites W2150987825 @default.
- W2138804577 cites W2160899690 @default.
- W2138804577 cites W4234329496 @default.
- W2138804577 cites W50012954 @default.
- W2138804577 doi "https://doi.org/10.1517/13543784.9.4.885" @default.
- W2138804577 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11060717" @default.
- W2138804577 hasPublicationYear "2000" @default.
- W2138804577 type Work @default.
- W2138804577 sameAs 2138804577 @default.
- W2138804577 citedByCount "32" @default.
- W2138804577 countsByYear W21388045772012 @default.
- W2138804577 countsByYear W21388045772013 @default.
- W2138804577 countsByYear W21388045772015 @default.
- W2138804577 countsByYear W21388045772016 @default.
- W2138804577 countsByYear W21388045772017 @default.
- W2138804577 countsByYear W21388045772018 @default.
- W2138804577 countsByYear W21388045772019 @default.
- W2138804577 countsByYear W21388045772020 @default.
- W2138804577 countsByYear W21388045772021 @default.
- W2138804577 crossrefType "journal-article" @default.
- W2138804577 hasAuthorship W2138804577A5026124381 @default.
- W2138804577 hasAuthorship W2138804577A5041407449 @default.
- W2138804577 hasConcept C126322002 @default.
- W2138804577 hasConcept C134018914 @default.
- W2138804577 hasConcept C2777056448 @default.
- W2138804577 hasConcept C2777180221 @default.
- W2138804577 hasConcept C2778199505 @default.
- W2138804577 hasConcept C2778345441 @default.
- W2138804577 hasConcept C2778881409 @default.
- W2138804577 hasConcept C2779306644 @default.
- W2138804577 hasConcept C2780323712 @default.
- W2138804577 hasConcept C2781281211 @default.
- W2138804577 hasConcept C555293320 @default.
- W2138804577 hasConcept C71924100 @default.
- W2138804577 hasConcept C98274493 @default.
- W2138804577 hasConceptScore W2138804577C126322002 @default.
- W2138804577 hasConceptScore W2138804577C134018914 @default.
- W2138804577 hasConceptScore W2138804577C2777056448 @default.
- W2138804577 hasConceptScore W2138804577C2777180221 @default.
- W2138804577 hasConceptScore W2138804577C2778199505 @default.
- W2138804577 hasConceptScore W2138804577C2778345441 @default.
- W2138804577 hasConceptScore W2138804577C2778881409 @default.
- W2138804577 hasConceptScore W2138804577C2779306644 @default.
- W2138804577 hasConceptScore W2138804577C2780323712 @default.
- W2138804577 hasConceptScore W2138804577C2781281211 @default.
- W2138804577 hasConceptScore W2138804577C555293320 @default.
- W2138804577 hasConceptScore W2138804577C71924100 @default.
- W2138804577 hasConceptScore W2138804577C98274493 @default.
- W2138804577 hasIssue "4" @default.
- W2138804577 hasLocation W21388045771 @default.
- W2138804577 hasLocation W21388045772 @default.
- W2138804577 hasOpenAccess W2138804577 @default.
- W2138804577 hasPrimaryLocation W21388045771 @default.
- W2138804577 hasRelatedWork W2060817917 @default.
- W2138804577 hasRelatedWork W2080135029 @default.
- W2138804577 hasRelatedWork W2109671400 @default.
- W2138804577 hasRelatedWork W2129737421 @default.
- W2138804577 hasRelatedWork W2153745306 @default.
- W2138804577 hasRelatedWork W2171424789 @default.
- W2138804577 hasRelatedWork W2358577232 @default.
- W2138804577 hasRelatedWork W2385315780 @default.
- W2138804577 hasRelatedWork W2387489669 @default.
- W2138804577 hasRelatedWork W2951697433 @default.
- W2138804577 hasVolume "9" @default.
- W2138804577 isParatext "false" @default.
- W2138804577 isRetracted "false" @default.
- W2138804577 magId "2138804577" @default.
- W2138804577 workType "article" @default.